Surviving Sengstaken

Area of Science:

• Pediatric Gastroenterology
• Interventional Endoscopy
• Hepatology

Background:

• Life-threatening hematemesis in children is a critical medical emergency.
• Gastrointestinal bleeding, particularly from esophageal varices, poses significant risks.
• Effective temporary measures are crucial for stabilizing these patients.

Purpose of the Study:

• To evaluate the outcomes of pediatric patients treated with Sengstaken-Blakemore tube (SBT) insertion for severe hematemesis.
• To identify the efficacy and complications associated with SBT use in children.
• To assess the long-term management and survival rates following SBT insertion.

Main Methods:

• Retrospective review of pediatric patients undergoing SBT insertion between 1997 and 2012 at a single institution.
• Collection of data on patient demographics, diagnoses, and clinical outcomes.
• Analysis of complications, mortality, and subsequent treatment strategies.

Main Results:

• Nineteen children, primarily with gastroesophageal varices secondary to conditions like biliary atresia and portal vein thrombosis, were included.
• Six children (31%) died, with complications including mucosal ulceration and pressure necrosis.
• Of the survivors, 5 required liver transplantation, 2 underwent shunt procedures, and 6 received endoscopic variceal obliteration.

Conclusions:

• The Sengstaken-Blakemore tube serves as an effective, temporary measure for life-threatening hematemesis in children.
• SBT use is associated with significant complications and mortality, highlighting the need for prompt definitive management.
• Long-term outcomes require interventions such as transplantation, shunting, or endoscopic obliteration.